DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Ubicación actual:
> This Story

Forward Printable StoryPrint Comment




Rad Oncology Homepage

INSIGHTEC receives CE Mark for Exablate Neuro for Siemens Healthineers MR scanners

Rutherford Cancer Centre South Wales approved by NHS Wales to provide proton therapy treatment for adults

Paul Scherrer Institute utilizing Varian Eclipse for IMPT proton treatment planning

Varian-equipped Emory proton therapy center opens

Radiation therapy’s pivotal role in treating breast cancer featured at SABCS 2018

Accuray CyberKnife System treatment delivery times up to 50 percent faster with software upgrade

Hygeia Hospital adopts RTsafe technology to enhance patient-specific safety in brain cancer radiotherapy

HollandPTC opens with ProBeam from Varian

Varian Halcyon receives China NMPA approval

MSH selects seven Varian linear accelerators to expand treatment capabilities across South Africa

Alliance for Proton Therapy Access emphasizes power of protons during National Sarcoma Awareness Month

Press releases may be edited for formatting or style
WASHINGTON – In recognition of National Sarcoma Awareness Month in July, the Alliance for Proton Therapy Access is underscoring the importance of patient access to proton radiation therapy, a clinically-effective treatment for patients diagnosed with sarcoma cancers.

Proton therapy is an FDA-cleared treatment that allows physicians to precisely control and conform the bulk of its cancer-fighting proton energy field on the cancerous cells, thereby minimizing extraneous radiation dose to healthy tissues, preserving organ function, and potentially reducing harmful side effects. This makes the treatment ideal for some sarcoma cancer patients, as sarcoma tumors are often located near sensitive tissues. One study shows that high-dose proton therapy controls more than half of spinal chordomas and chondrosarcomas and compares favorably with historical traditional (photon) radiation data.

Story Continues Below Advertisement

Dunlee announces the relaunch of DA135 CT/e, DA165NP and Akron tubes

Dunlee announces the return of the DA135 CT/e, DA165NP, S532B and S532Q(known as the Akron tubes) CT Replacement tubes, making its full portfolio of CT tubes for GE and Siemens CT scanners available once again.Click to learn more

"The successful treatment of my recurrent sarcoma cancer illustrates the power of proton therapy. I am living proof that proton therapy is a legitimate, safe, and effective cancer treatment," said Cindy Lee, a cancer survivor and advocate. "I encourage others to join me in advocating for policies that ensure timely access to treatment for cancer patients in need of proton therapy."

Despite the benefits of proton therapy for treating sarcoma and other cancers, patients too often face insurers' delays or denials when physicians recommend proton therapy. The Alliance is working with cancer patients and family caregivers to call on insurance commissioners to adopt and enforce principles of the Cancer Patients' Timely Treatment Bill of Rights and hold insurers accountable for providing fair, timely, and transparent access to cancer treatment.

"During National Sarcoma Awareness Month, we recognize the important role proton therapy has in treating sarcoma patients," said Daniel Smith, Executive Director of the Alliance for Proton Therapy Access. "We are proud to provide cancer patients a platform to speak out about the value of proton therapy in cancer care, and the need for fair, timely, and transparent insurance payment decisions for all cancer patients."

According to the American Cancer Society, an estimated 13,040 people will be diagnosed with new soft tissue sarcomas in 2018.

About the Alliance for Proton Therapy Access
The Alliance for Proton Therapy Access is an advocacy organization comprised of a growing community of patients, families, caregivers, physicians, and industry partners working together to make sure all cancer patients seeking proton therapy receive fair and timely payment decisions from their health insurers. The Alliance is governed by a Board of Directors made up of patients, physicians and industry partners. Sign up to be an advocate and learn more about the Alliance at Follow the Alliance on Facebook and Twitter.

Back to HCB News
  Pages: 1

Rad Oncology Homepage

You Must Be Logged In To Post A Comment

Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2018, Inc.